Concepedia

Peter H. Dorff

PH

Statistics

Publications

16

Citations

1.1K

H-Index

15

Active since

1988

Affiliations

Pfizer (United States)(Current)

Sterling Research Group (United States)

Peter H. Dorff is an author at Pfizer (United States) specializing in medicinal chemistry, drug discovery, and pharmacy.

Publications per year

1988–2021

16

Publications

16

Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor

Antonia F. Stepan, Chakrapani Subramanyam, Ivan Efremov et al. · Journal of Medicinal Chemistry · 2012 · 446 citations · Full text

, , +17

A solid phase CBZ chloride equivalent — a new matrix specific linker

James R. Hauske, Peter H. Dorff · Tetrahedron Letters · 1995 · 113 citations

, , +8

Metabolism-Directed Design of Oxetane-Containing Arylsulfonamide Derivatives as γ-Secretase Inhibitors

Antonia F. Stepan, Kapil Karki, W. Scott McDonald et al. · Journal of Medicinal Chemistry · 2011 · 106 citations · Full text

, , +17

Mammalian topoisomerase II inhibitory activity of 1-cyclopropyl-6,8-difluoro-1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-3-quinolinecarboxylic acid and related derivatives

Mark P. Wentland, George Y. Lesher, Michael Reuman et al. · Journal of Medicinal Chemistry · 1993 · 73 citations · Full text

, , +10

Discovery and Optimization of a Novel Spiropyrrolidine Inhibitor of β-Secretase (BACE1) through Fragment-Based Drug Design

Ivan Efremov, F.F. Vajdos, Kris A. Borzilleri et al. · Journal of Medicinal Chemistry · 2012 · 63 citations · Full text

, , +17

1–5 of 16